Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Kotecha
Dr. Ritesh Kotecha is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Albany Medical College and has been in practice 6 years. He is one of 508 doctors at Memorial Sloan Kettering Cancer Center and one of 13 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. He has more than 50 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2014 - 2017
Albany Medical CollegeClass of 2014, MD
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2017 - 2026
PA State Medical License 2023 - 2026
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer Start of enrollment: 2020 Apr 06
Roles: Principal Investigator, Contact
- Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma Start of enrollment: 2019 Aug 22
Roles: Contact, Principal Investigator
- A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain Start of enrollment: 2023 Nov 10
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone.Daniel Barbakoff, Mark T Dawidek, Andrea Knezevic, Marc Ganz, Lina Posada
Urologic Oncology. 2025-09-11 - Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma.Stephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, Andrea Knezevic, Kelly Fitzgerald
Urologic Oncology. 2025-09-05 - 1 citationsA Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.Sumanta K Pal, Alice Bernard-Tessier, Peter Grell, Xin Gao, Ritesh R Kotecha
Clinical Cancer Research. 2025-05-15
Press Mentions
CAR T-cell Therapy for Kidney Cancer Builds on Efficacy RecordNovember 9th, 2024- Memorial Sloan Kettering Awards and AppointmentsOctober 16th, 2020
- Breaking down Genomic Data: An in-Depth Look at Ancestry and Tumor Biology in Kidney Cancer - Ritesh KotechaJuly 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
